Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
40.78
-1.27 (-3.02%)
At close: Dec 12, 2025, 4:00 PM EST
41.68
+0.90 (2.21%)
After-hours: Dec 12, 2025, 4:39 PM EST

Rigel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
740296253259453591
Upgrade
Market Cap Growth
61.06%17.18%-2.48%-42.79%-23.38%64.89%
Upgrade
Enterprise Value
665335295269403560
Upgrade
Last Close Price
40.8316.8214.5015.0026.5035.00
Upgrade
PE Ratio
6.5816.95----
Upgrade
Forward PE
10.1717.39----
Upgrade
PS Ratio
2.581.652.182.243.275.45
Upgrade
PB Ratio
6.3090.11-8.83-19.0414.9217.38
Upgrade
P/TBV Ratio
8.03---14.9217.38
Upgrade
P/FCF Ratio
10.889.43--86.30-
Upgrade
P/OCF Ratio
10.879.41--77.10-
Upgrade
EV/Sales Ratio
2.361.872.552.332.905.15
Upgrade
EV/EBITDA Ratio
5.4812.69----
Upgrade
EV/EBIT Ratio
5.5913.86----
Upgrade
EV/FCF Ratio
9.7610.67--76.67-
Upgrade
Debt / Equity Ratio
0.5230.40-3.64-6.443.011.15
Upgrade
Debt / EBITDA Ratio
0.503.68----
Upgrade
Debt / FCF Ratio
0.893.18--17.38-
Upgrade
Asset Turnover
1.481.270.920.771.000.84
Upgrade
Inventory Turnover
3.315.492.765.1710.8212.21
Upgrade
Quick Ratio
1.941.881.641.512.211.80
Upgrade
Current Ratio
2.282.131.861.782.432.18
Upgrade
Return on Equity (ROE)
220.06%---699.04%-55.63%-67.72%
Upgrade
Return on Assets (ROA)
38.93%10.75%-10.68%-24.34%-8.77%-14.04%
Upgrade
Return on Capital (ROIC)
56.31%16.92%-17.95%-37.50%-12.50%-22.19%
Upgrade
Return on Capital Employed (ROCE)
80.30%24.00%-33.60%-85.00%-18.80%-41.70%
Upgrade
Earnings Yield
15.29%5.90%-9.92%-22.59%-3.95%-5.03%
Upgrade
FCF Yield
9.19%10.61%-2.27%-28.62%1.16%-9.04%
Upgrade
Buyback Yield / Dilution
-4.06%-1.64%-2.07%0.00%-1.03%-0.81%
Upgrade
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q